首页 > 市场调查报告书 > 医疗设备

美容整形

市场调查报告书

商品编码

1566212

肉毒桿菌毒素市场规模、份额、成长分析、按产品、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

Botulinum Toxin Market Size, Share, Growth Analysis, By Product (Type A, Type B), By Application (Aesthetic, Therapeutic), By End User (Hospitals, Dermatology Clinics), By Region - Industry Forecast 2024-2031

出版日期: 2024年10月06日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球肉毒桿菌毒素市场规模将为100.1亿美元，预测期间（2024-2031年）复合年增长率为9.83%，从2023年的111.2亿美元成长至235.4亿美元。

由于旨在将治疗应用扩展到目前用途之外的研究和开发的进步，以及对美容和非侵入性手术的需求不断增加，全球肉毒桿菌（BNT）市场预计将出现显着增长。七种血清型的着名产品包括有限种类的 BNT-A 和单一产品 BNT-B，凸显了市场多元化和创新的潜力。新产品推出的趋势，加上患者负担能力的提高和不断变化的报销政策（包括肉毒桿菌注射的保险范围）进一步支持了这一增长。由于消费者对美容疗程的兴趣显着增加，美国肉毒桿菌毒素市场预计将在未来的预测期内实现持续的复合年增长率。公司在研发方面的策略性投资将加强产品系列，并导致肉毒桿菌毒素在美容和治疗领域中得到更广泛的接受。总体而言，这些因素的结合使肉毒毒素市场成为医疗保健产业中充满活力的细分市场，前景看好。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Ipsen Group
Allergan Inc.
Medy-Tox, Inc.
Metabiologics
Merz Pharma
Supernus Pharmaceutical
Evolus
Galderma
Lanzhou Institute of Biological Products
Revance Therapeutics
Hugel
Suneva Medical
Daewoong Pharmaceutical
Mylan
Teijin Pharma
Eisai
Prollenium Medical

简介目录

Product Code: SQMIG35I2220

Global Botulinum Toxin Market size was valued at USD 10.01 billion in 2022 and is poised to grow from USD 11.12 billion in 2023 to USD 23.54 billion by 2031, growing at a CAGR of 9.83% during the forecast period (2024-2031).

The global botulinum toxin (BNT) market is poised for significant growth, driven by increasing demand for cosmetic and non-invasive procedures, alongside advancements in research and development aimed at expanding therapeutic applications beyond its current uses. Comprising seven antigenic forms, notable products include a limited array of BNT-A and a singular BNT-B offering, underscoring the potential for market diversification and innovation. The trend towards new product launches, coupled with improving patient affordability and evolving reimbursement policies that now include coverage for botulinum injections, further propels this growth. With a notable increase in consumer interest in aesthetic treatments, the U.S. market for botulinum toxin is expected to experience a sustainable compound annual growth rate (CAGR) in the forthcoming forecast period. As companies invest strategically in R&D, this will enhance the product portfolio and encourage broader acceptance of botulinum toxin in both cosmetic and therapeutic domains. Overall, the confluence of these factors suggests a promising trajectory ahead for the botulinum toxin market, positioning it as a dynamic segment within the healthcare industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Botulinum Toxin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Botulinum Toxin Market Segmental Analysis

Global Botulinum Toxin Market is segmented by Product, Application, End User, and Region. Based on Product, the market is segmented into Type A (Botox, Dysport, Xeomin, Others), Type B. Based on Application, the market is segmented into Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others), Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others). Based on End User, the market is segmented into Hospitals, Dermatology Clinics, Cosmetic Centers and Medspas. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Botulinum Toxin Market

The increasing demand for minimally invasive cosmetic procedures is a significant market driver for the global botulinum toxin market. As more individuals seek non-surgical options to achieve youthful appearances with minimal recovery time, botulinum toxin treatments have become increasingly popular for reducing wrinkles and fine lines. This trend is further fueled by a growing awareness of the benefits of aesthetic procedures, enhanced by social media influence and celebrity endorsements. Additionally, advancements in technology and product formulations have improved the effectiveness and safety of botulinum toxin therapies, thereby expanding their application in both cosmetic and therapeutic settings, propelling market growth.

Restraints in the Global Botulinum Toxin Market

The global botulinum toxin market may face significant restraints due to the potential side effects associated with its use. Adverse reactions, including muscle weakness, allergic reactions, and localized pain, can deter patients from seeking treatments, thus impacting market growth. Additionally, the perception of safety risks can influence healthcare professionals' recommendations, further complicating patient acceptance. Regulatory scrutiny surrounding the approval and marketing of botulinum toxin products may also pose challenges, as companies must navigate stringent guidelines while addressing concerns related to side effects. The cumulative effect of these factors could inhibit the expansion of the market and limit its overall potential.

Market Trends of the Global Botulinum Toxin Market

The global botulinum toxin market is witnessing significant growth, driven predominantly by cosmetic procedures favored by women, who constitute a remarkable 92% of all treatments. With a rising number of individuals over 40 prioritizing their physical appearance, especially in developed nations, the demand for aesthetics enhancements continues to surge. This trend is emphasized by the remarkable statistic of over 2.5 million women aged 40-54 undergoing botulinum toxin procedures in 2020 alone. As societal norms around beauty evolve, this market trend indicates robust prospects for botulinum toxin, with a sustained focus on anti-aging solutions likely to propel its expansion well into the future.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
PESTEL Analysis
Technology Analysis
Regulatory Landscape

Botulinum Toxin Market, By Product

Market Overview
Type A
- Botox
- Dysport
- Xeomin
- Others
Type B

Botulinum Toxin Market, By Application

Market Overview
Therapeutic
- Chronic Migraine
- Overactive Bladder
- Cervical Dystonia
- Spasticity
- Others
Aesthetic
- Glabellar Lines
- Crow's Feet
- Forehead Lines
- Others

Botulinum Toxin Market, By End User

Market Overview
Hospitals
Dermatology Clinics
Cosmetic Centers and Medspas

Botulinum Toxin Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Ipsen Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medy-Tox, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Metabiologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merz Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Supernus Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evolus
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Galderma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lanzhou Institute of Biological Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revance Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hugel
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Suneva Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daewoong Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teijin Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eisai
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prollenium Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments